Consistent with previous work in subcutaneous xenograft models of pancreatic carcinomas (Ghaneh et al, 2001; Cascallo et al, 2005), we found that wt TP53 restoration distinctly reduces primary tumour growth during both the early and late stages of orthotopic tumour growth. Here, TP53 is linked to exocrine pancreatic carcinoma.